SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 10/11/2019 | 3. Issuer Name and Ticker or Trading Symbol Bio-Matrix Scientific Group, Inc. [ BMSN ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 12,500,000 | I | Trustee Sherman Family Trust |
Common Stock | 792,500 | I | Trustee Bio-Technology Partners Business Trust |
Common Stock | 3,020,143 | I | President Dunhill Ross Partners, Inc(1) |
Common Stock | 437,143 | I | President BioScientific Consultants |
Common Stock | 3,757 | I | President Sunset Cliffs Compliance |
Preferred Stock | 1,068 | I | President BioScientific Consultants |
Preferred Stock | 2,300 | I | Trustee Bio-Technology Partners Business Trust |
Preferred Stock | 1,187 | I | President Dunhill Ross Partners(1) |
Preferred Series B Stock | 2,678 | I | President BioScientific Consultants |
Preferred Series B Stock | 179 | I | Trustee Bio-Technology Partners Business Trust |
Preferred Series B Stock | 2,041 | I | President Dunhill Ross Partners(1) |
Preferred Series B Stock | 75 | I | President Sunset Cliffs Compliance |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Formerly Venture Bridge Advisors, Inc |
Remarks: |
On May 23,2013 Venture Bridge Advisors, Inc (a Nevada Corporation) changes its name to Dunhill Ross Partners, Inc (A Nevada Corporation). The stock in Venture Bridge Advisors name predates this name change and has not been reissued. |
Timothy G Foat | 12/23/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |